Clermont-Ferrand). Ph ,
Degroodt (Lyon) Potential conflict of interest: I.P-M. has had associations with Gilead, BMS, AbbVie and MSD. C.A. has had associations with BMS ,
Has had associations with ViiV has had associations with Gilead and MSD. L.C. had associations with BMS and ViiV Healthcare, C.K. has had associations with Gilead ,
Immunological recovery and antiretroviral therapy in HIV-1 infection, The Lancet Infectious Diseases, vol.6, issue.5, pp.280-287, 2006. ,
DOI : 10.1016/S1473-3099(06)70463-7
CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years<subtitle>The Swiss HIV Cohort Study</subtitle>, Archives of Internal Medicine, vol.163, issue.18, pp.2187-95, 2003. ,
DOI : 10.1001/archinte.163.18.2187
CD4+ Cell Count 6 Years after Commencement of Highly Active Antiretroviral Therapy in Persons with Sustained Virologic Suppression, Clinical Infectious Diseases, vol.44, issue.3, pp.441-447, 2007. ,
DOI : 10.1086/510746
CD4 Cell Counts of 800 Cells/mm3 or Greater After 7 Years of Highly Active Antiretroviral Therapy Are Feasible in Most Patients Starting With 350 Cells/mm3 or Greater, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.45, issue.2, pp.183-92, 2007. ,
DOI : 10.1097/QAI.0b013e31804d685b
Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study, The Lancet, vol.370, issue.9585, pp.407-420, 2007. ,
DOI : 10.1016/S0140-6736(07)60948-9
Long-term evolution of CD4 count in patients with a plasma HIV RNA persistently <500 copies/mL during treatment with antiretroviral drugs, HIV Medicine, vol.88, issue.3, pp.156-63, 2007. ,
DOI : 10.1086/427340
T-Cell Counts in a Large Cohort of HIV-Infected Individuals, Journal of Infectious Diseases, vol.211, issue.11, pp.1726-1760, 2015. ,
DOI : 10.1093/infdis/jiu669
Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia, AIDS, vol.20, issue.8, pp.1141-50, 2006. ,
DOI : 10.1097/01.aids.0000226954.95094.39
CD4+ T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy, Antivir Ther, vol.12, pp.889-97, 2007. ,
A large French prospective cohort of HIV-infected patients: the Nadis Cohort, HIV Medicine, vol.10, issue.8, pp.504-515, 2009. ,
DOI : 10.1111/j.1468-1293.2009.00719.x
development of an electronic medical record for patients infected by HIV, HBV and HCV], NADIS Presse Med, vol.32, pp.299-303, 2000. ,
Lymphocyte subset reference ranges in adult caucasians, Clinical Immunology and Immunopathology, vol.60, issue.2, pp.190-208, 1991. ,
DOI : 10.1016/0090-1229(91)90063-G
Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy, AIDS, vol.29, issue.12, pp.1505-1515, 2015. ,
DOI : 10.1097/QAD.0000000000000650
CD28-Negative CD4+ and CD8+ T Cells in Antiretroviral Therapy-Naive HIV-Infected Adults Enrolled in Adult Clinical Trials Group Studies, Journal of Infectious Diseases, vol.205, issue.11, pp.1730-1738, 2012. ,
DOI : 10.1093/infdis/jis260
The role of CD8+ T-cell replicative senescence in human aging, Immunological Reviews, vol.908, issue.1, pp.147-57, 2005. ,
DOI : 10.2174/1570162033485348
T-cell subset alterations in HIV-infected homosexual men: NIAID multicenter AIDS cohort study, Clinical Immunology and Immunopathology, vol.52, issue.1, pp.10-18, 1989. ,
DOI : 10.1016/0090-1229(89)90188-8
CD4 T Cell Depletion Is Linked Directly to Immune Activation in the Pathogenesis of HIV-1 and HIV-2 but Only Indirectly to the Viral Load, The Journal of Immunology, vol.169, issue.6, pp.3400-3406, 2002. ,
DOI : 10.4049/jimmunol.169.6.3400
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load, Blood, vol.104, issue.4, pp.942-949, 2004. ,
DOI : 10.1182/blood-2003-09-3333
CD8+ T-Lymphocyte Activation in HIV-1 Disease Reflects an Aspect of Pathogenesis Distinct From Viral Burden and Immunodeficiency, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol.18, issue.4, pp.332-372, 1998. ,
DOI : 10.1097/00042560-199808010-00004
Shortened telomeres in the expanded CD28-CD8+ cell subset in HIV disease implicate replicative senescence in HIV pathogenesis, AIDS, vol.10, issue.8, pp.17-22, 1996. ,
DOI : 10.1097/00002030-199607000-00001
Immunosenescence is associated with presence of Kaposi??s sarcoma in antiretroviral treated HIV infection, AIDS, vol.27, issue.11, pp.1735-1777, 2013. ,
DOI : 10.1097/QAD.0b013e3283601144
Impact of Inversion of the CD4/CD8 Ratio on the Natural History of HIV-1 Infection, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.42, issue.5, pp.620-626, 2006. ,
DOI : 10.1097/01.qai.0000223028.55080.9d
Multiparametric Bioinformatics Distinguish the CD4/CD8 Ratio as a Suitable Laboratory Predictor of Combined T Cell Pathogenesis in HIV Infection, The Journal of Immunology, vol.192, issue.5, pp.2099-108, 2014. ,
DOI : 10.4049/jimmunol.1302596
The CD4/CD8 ratio as a marker T-cell activation, senescence and activation/exhaustion in treated HIV-infected children and young adults, AIDS, vol.27, issue.9, pp.1513-1519, 2013. ,
DOI : 10.1097/QAD.0b013e32835faa72
Dynamics of Immune Reconstitution and Activation Markers in HIV+ Treatment-Na??ve Patients Treated with Raltegravir, Tenofovir Disoproxil Fumarate and Emtricitabine, PLoS ONE, vol.203, issue.12, p.83514, 2013. ,
DOI : 10.1371/journal.pone.0083514.s002
Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America, AIDS, vol.27, pp.803-816, 2002. ,